2Salvemini D, Cuzzocrea S. Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine. Critical Care Medicine,2003, 31(1) Suppl:S29～S38.
3Cuzzocrea S, Mazzon E, Dugo L, et al. Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion. Br J Pharmacol,2001, 132:19～29.
4Li Q, Bolli R, Qiu Y, et al. Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation,2001, 103:1 893～1 898.
6Chen Z, Oberley TD, Ho Y, et al. Overexpression of Cu-Zn SOD in coronary vascular cells attenuates myocardial ischemia/reperfusion injury. Free Radic Biol Med,2000, 29:589～596.
7Day BJ, Bantinic-Haberle J, Crapo JD. Metalloporphyrins are potent inhibitors of lipid peroxidation. Free Radic Biol Med,1999, 26:730～736.
8Crow JP. Peroxynitrite scavenging by metalloporphyrins and thiolates. Free Radic Biol Med,2000, 28:1 487～1 494.
9Bianca R, Wayman N, McDonald M, et al. Superoxide dismutase mimetic with catalase activity, EUK-134, attenuates the multiple organ injury and dysfunction caused by endotoxin in the rat. Med Sci Monit,2002, 8(1):1～7.
